ELYSEE Arranges Private Placement for $1.4 Million and Announces Private Equity Investment in Baker Street Scientific Corp.

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Vancouver, British Columbia--(Newsfile Corp. - September 17, 2018) - Elysee Development Corp. (TSXV: ELC) is pleased to announce that it has agreed to a non-brokered private placement of 4,000,000 common shares at a price of $0.35 cents per share for gross proceeds of $1,400,000. There will be no warrants issued to the placees in conjunction with this placement.

Closing of this private placement is subject to acceptance for filing by the TSX Venture Exchange. All shares issued will be subject to a four-month hold period from the date of issuance.

Elysee has also agreed to invest US$300,000 in convertible notes of Baker Street Scientific Corp (BakerSCI), a private early stage "big data" analytics company located near Atlanta, Georgia.

Since its inception in 2014, Baker SCI has conceived and developed revolutionary analytics science and technologies ("S&T") with specific novel capabilities that have proven to be unparalleled by other analytics companies' applications. Baker SCI's disruptive S&T lets the data tell its own story to reveal extraordinarily deep context and unknowns in the data.

Baker SCI's S&T's compelling results have repeatedly been shown to be very impactful and valuable across the healthcare, defense, oil & gas, financial services, communications and internet business sectors, resulting in a number of initial contracts that offer significant revenue potential in the immediate future. For more information, please reference www.bakersci.com.

Guido Cloetens, the Chief Executive Officer of Elysee, stated: "This investment in Baker SCI is Elysee's first significant investment in a privately held company. We aim to augment our overall return on investment through increasing our exposure to private equity investments in the future through leveraging existing relationships with experienced and successful private equity investors with whom we have worked in the past".

For more information on Elysee, please visit our website at www.elyseedevelopment.com.

FOR FURTHER INFORMATION, PLEASE CONTACT:

Stuart Rogers
President 
Elysee Development Corp.
Tel: (604) 689-1749

Guido Cloetens
Chairman and CEO
[email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as the term is defined in the Policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements - This news release contains certain forward-looking statements that are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements. The Company does not undertake to update any forward-looking statements, oral or written, made by itself or on its behalf, except as required by applicable law.

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).